Federal
Register Notices > Importers
>
Wildlife Laboratories
FR Doc E7-14648 [Federal Register: July 30, 2007 (Volume 72, Number 145)]
[Notices] [Page 41527-41528] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30jy07-77]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing a registration
under this Section to a bulk manufacturer of a controlled substance in
schedule I or II and prior to issuing a registration under 21
U.S.C. 952(a)(2) authorizing the importation of such a substance, provide
manufacturers holding registrations for the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21
CFR 1301.34(a), this is notice that on June 6, 2007, Wildlife
Laboratories, 1401 Duff Drive, Suite 400, Fort Collins, Colorado 80524, made
application by renewal to the Drug Enforcement Administration (DEA) to be
registered as an importer of Etorphine Hydrochloride (9059),a basic class of
controlled substance listed in schedule II.
The company plans to import the listed controlled substance for sale to its
customers.
Any bulk manufacturer who is presently, or is applying to be, registered
with DEA to manufacture such basic class of controlled substance may file
comments or objections to the issuance of the proposed registration and may,
at the same time, file a written request for a hearing on such application
pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections being sent via regular mail should be
addressed, in quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), Washington, DC
20537, or any being sent via express mail should be sent to Drug Enforcement
Administration, Office of Diversion Control, Federal Register Representative (ODL),
2401 Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed no
later than August 29, 2007. This procedure is to be conducted simultaneously
with, and independent
[[Page 41528]]
of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f).
As noted in a previous notice published in the Federal Register on September
23, 1975, (40 FR 43745-46), all applicants for registration to import a basic
class of any controlled substances in schedule I or II are and will continue
to be required to demonstrate to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21
U.S.C. 958(a); 21
U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.
Dated: July 24, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-14648 Filed 7-27-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|